alexotherapeutics.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:

Meta Tags

Title	ALX
Description	Latest News updated at 13:50:31 Home Company About Us Leadership Management Board of Directors Scientific Advisory Board Science Evorpacept Publications Pipeline Clinical Trials Expanded
Keywords	N/A

Server Information

WebSite	alexotherapeutics.com
Host IP	104.198.12.215
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

marutiengineering.net

jaipurpolo.com

fogcanada.org

royaljaipurpolofoundation.com

awscloudengineer.com

eleven41.com

lowtnation.com

globalschoolgurugram.com

zoekeating.tumblr.com

albertawhmistraining.com

alexotherapeutics.com Valuation

US$910

Last updated: 2023-05-14 22:04:56

alexotherapeutics.com has Semrush global rank of 0. alexotherapeutics.com has an estimated worth of US$ 910, based on its estimated Ads revenue. alexotherapeutics.com receives approximately 105 unique visitors each day. Its web server is located in United States, with IP address 104.198.12.215. According to SiteAdvisor, alexotherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$910
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$25
Yearly Ads Revenue	US$302
Daily Unique Visitors	7
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
alexotherapeutics.com.	A	298	IP: 104.198.12.215
alexotherapeutics.com.	NS	86400	NS Record: ns3.p28.dynect.net.
alexotherapeutics.com.	NS	86400	NS Record: ns4.p28.dynect.net.
alexotherapeutics.com.	NS	86400	NS Record: ns1.p28.dynect.net.
alexotherapeutics.com.	NS	86400	NS Record: ns2.p28.dynect.net.
alexotherapeutics.com.	MX	300	MX Record: 50 aspmx2.googlemail.com.
alexotherapeutics.com.	MX	300	MX Record: 50 aspmx3.googlemail.com.
alexotherapeutics.com.	MX	300	MX Record: 30 alt1.aspmx.l.google.com.
alexotherapeutics.com.	MX	300	MX Record: 30 alt2.aspmx.l.google.com.
alexotherapeutics.com.	MX	300	MX Record: 10 aspmx.l.google.com.
alexotherapeutics.com.	TXT	3600	TXT Record: google-site-verification=d5GjUW2UyX5URP4dH3aBa_f7H5qCzvhs7vQzSebjsZs

HtmlToTextCheckTime:2023-05-14 22:04:56

Home Company About Us Leadership Management Board of Directors Scientific Advisory Board Science Evorpacept Publications Pipeline Clinical Trials Expanded Access Policy Careers Current Jobs Investors Overview News & Events Stock Information Corporate Governance Financials & Filings IR Resources Contact We’ve developed a new approach to CD47 blockade that is designed to maximize clinical activity and minimize toxicities MORE Our goal is to transform cancer treatment options for patients by developing evorpacept (ALX148) as a foundational checkpoint immunotherapy MORE Evorpacept Mechanism of Action ALX Oncology was founded by a team of industry veterans to address fundamental challenges in blocking CD47 and to realize the full potential of this therapeutic target. Cancer cells employ CD47, a cell surface protein, as a “don’t eat me” signal to evade detection by the immune system. ALX is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Fri, 24 Dec 2021 02:39:16 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 0
Connection: keep-alive
Keep-Alive: timeout=20
X-Redirect-By: WordPress
Location: https://alxoncology.com/
X-Powered-By: WP Engine
X-Cacheable: non200
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 1
X-Cache-Group: normal

HTTP/2 200 
server: nginx
date: Fri, 24 Dec 2021 02:39:16 GMT
content-type: text/html; charset=UTF-8
content-length: 48013
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes

alexotherapeutics.com Whois Information

Domain Name: ALEXOTHERAPEUTICS.COM
Registry Domain ID: 1889063832_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.name.com
Registrar URL: http://www.name.com
Updated Date: 2020-05-04T00:51:20Z
Creation Date: 2014-12-07T01:16:55Z
Registry Expiry Date: 2026-12-07T01:16:55Z
Registrar: Name106, Inc.
Registrar IANA ID: 1040
Registrar Abuse Contact Email: abuse@name.com
Registrar Abuse Contact Phone: +1.7203101849
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.P28.DYNECT.NET
Name Server: NS2.P28.DYNECT.NET
Name Server: NS3.P28.DYNECT.NET
Name Server: NS4.P28.DYNECT.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-27T12:06:23Z <<<

alexotherapeutics.com valuation and analysis